Cargando…

Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial

Detalles Bibliográficos
Autores principales: Franchini, G, Pegu, P, Gordon, S, Keele, B, Doster, M, Guan, Y, Ferrari, G, Pal, R, Ferrari, MG, Whitney, S, Hudacik, L, Billings, E, Rao, M, Montefiori, D, Venzon, D, Fenizia, C, Lifson, J, Stablein, D, Tartaglia, J, Michael, N, Kim, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441518/
http://dx.doi.org/10.1186/1742-4690-9-S2-O2
_version_ 1782243308392677376
author Franchini, G
Pegu, P
Gordon, S
Keele, B
Doster, M
Guan, Y
Ferrari, G
Pal, R
Ferrari, MG
Whitney, S
Hudacik, L
Billings, E
Rao, M
Montefiori, D
Venzon, D
Fenizia, C
Lifson, J
Stablein, D
Tartaglia, J
Michael, N
Kim, J
author_facet Franchini, G
Pegu, P
Gordon, S
Keele, B
Doster, M
Guan, Y
Ferrari, G
Pal, R
Ferrari, MG
Whitney, S
Hudacik, L
Billings, E
Rao, M
Montefiori, D
Venzon, D
Fenizia, C
Lifson, J
Stablein, D
Tartaglia, J
Michael, N
Kim, J
author_sort Franchini, G
collection PubMed
description
format Online
Article
Text
id pubmed-3441518
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34415182012-09-18 Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial Franchini, G Pegu, P Gordon, S Keele, B Doster, M Guan, Y Ferrari, G Pal, R Ferrari, MG Whitney, S Hudacik, L Billings, E Rao, M Montefiori, D Venzon, D Fenizia, C Lifson, J Stablein, D Tartaglia, J Michael, N Kim, J Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441518/ http://dx.doi.org/10.1186/1742-4690-9-S2-O2 Text en Copyright ©2012 Franchini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Franchini, G
Pegu, P
Gordon, S
Keele, B
Doster, M
Guan, Y
Ferrari, G
Pal, R
Ferrari, MG
Whitney, S
Hudacik, L
Billings, E
Rao, M
Montefiori, D
Venzon, D
Fenizia, C
Lifson, J
Stablein, D
Tartaglia, J
Michael, N
Kim, J
Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
title Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
title_full Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
title_fullStr Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
title_full_unstemmed Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
title_short Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
title_sort antibodies to the envelope protein protect macaques from sivmac251 acquisition in an immunization regimen that mimics the rv-144 thai trial
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441518/
http://dx.doi.org/10.1186/1742-4690-9-S2-O2
work_keys_str_mv AT franchinig antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT pegup antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT gordons antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT keeleb antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT dosterm antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT guany antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT ferrarig antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT palr antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT ferrarimg antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT whitneys antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT hudacikl antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT billingse antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT raom antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT montefiorid antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT venzond antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT feniziac antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT lifsonj antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT stableind antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT tartagliaj antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT michaeln antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial
AT kimj antibodiestotheenvelopeproteinprotectmacaquesfromsivmac251acquisitioninanimmunizationregimenthatmimicstherv144thaitrial